Portfolio
Biotech
-
Athena Neurosciences Pharmaceuticals for neurological diseases
Acquired by Elan Corp., plc
(ELN) -
Avidia New protein structural motifs for treating human disease.
Acquired by Amgen
(AMGN) -
-
Calithera Biosciences A new class of anti-cancer therapeutics based on activation of caspases
www.calithera.com
-
Catalyst Biosciences Developer of engineered proteases as protein therapeutics that attack targets which cause disease.
www.catbio.com
PRIVATE -
Elcelyx Therapeutics Elcelyx is a biotechnology company that is creating new therapeutics for the treatment of diabetes and obesity
-
FoldRx Pharmaceuticals Treatments for diseases caused by misfolding of specific proteins
www.foldrx.com
-
Galleon Pharmaceuticals Innovative medicines for pulmonology, neurology, cardiology, sleep medicine and pediatrics
www.galleonpharma.com
PRIVATE -
GlobeImmune Therapeutic vaccine platform technology targeting infectious disease and cancer
www.globeimmune.com
PRIVATE -
Morphotek, Inc. Next generation antibodies production technology.
www.morphotek.com
Acquired by EISIA -
OncoMed Pharmaceuticals Inc. Biological therapeutics targeting cancer stem cells
www.oncomed.com
PRIVATE -
-
-
Ra Pharmaceuticals Platform for orally available and cell permeable biologics
-
Replidyne Drug discovery and development focused on a new class of antibiotics
www.replidyne.com
(RDYN) -
Ribozyme Pharmaceuticals RNA-based pharmaceuticals for human disease
(RZYM) -
Sequana Therapeutics Gene discovery via functional genomics
Acquired by Axys Pharmaceutical
(AXPH) -
-
Threshold Pharmaceutical, Inc. Developing targeted therapies for treatment of cancer.
www.thresholdpharm.com
(THLD) -
Tragara Pharmaceuticals Developer of drugs for the treatment of cancer and inflammation-related diseases.
www.tragarapharma.com
PRIVATE -
Trellis Bioscience Platform technology for monoclonal antibody development and production
www.trellisbio.com
PRIVATE -
